Clinical Trials Browser

Completed × UNKNOWN × Erlotinib Hydrochloride × Clear all

NCT00600587 2013-06-25

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung